News | Brachytherapy Systems, Women's Healthcare | October 23, 2019

Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform

Non-invasive accelerated partial breast irradiation solution provides real-time image guidance and targeting confidence for breast brachytherapy

Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform

October 23, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost, announced the latest upgrades to the AccuBoost Digital platform. AccuBoost Digital leverages the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and targeting confidence in the delivery of accelerated partial breast irradiation (APBI) in patients opting for breast conserving therapy (BCT). These upgrades improve the treatment workflow, patient experience and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100 percent adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.

Adaptive therapy allows doctors the ability to alter the treatment plan based on tumor bed and anatomical changes as presented each day at the time of treatment. With AccuBoost Digital, doctors can locate the tumor bed in real time, and adjust the field size, shape and position as needed, while minimizing dose to a patients’ heart, lungs and healthy tissues. 

“If breast cancer patients could talk to their peers that are about to embark on a course of radiation therapy, they would readily be sold on AccuBoost. It is such a well-tolerated procedure. AccuBoost is the only option that we offer for APBI,” said Leann Smith, M.D., radiation oncologist at Cancer Centers of Southwest Oklahoma in Lawton, Okla.

For more information:

Related Content

Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...
The research evaluates the feasibility of biology-guided radiotherapy to treat metastatic cancer
News | Radiation Therapy | October 24, 2020
October 24, 2020 — ...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.